1+ Views

Carbon Fiber Market Business Opportunities, Growth Insights, Trends, Size to 2026

The global carbon fiber market analysis is expected to gain momentum owing to increasing demand for bicycles by fitness enthusiasts and increasing incidence of heart-related ailments across the globe.
Carbon fiber is a polymer that has high tensile strength and is lightweight. It is five times stronger than steel and is mainly composed of carbon atoms. It is made up of strong, thin crystalline filaments of carbon that imparts strength to a material. Additionally, it possesses a high chemical resistance property and is tolerant of excessive heat making it an ideal choice amongst designers and engineers during the manufacturing of materials.
ethodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
Increasing Demand for Bicycles to Favor Growth
According to the US Bicycle Industry, around 15 to 20 million units of bicycles are sold in the US every year. Increasing incidence of heart-related ailments and growing awareness regarding health and fitness amongst the people is expected to propel the demand for bicycles. Increasing demand for bicycles and technological advancement is driving the manufacturers to produce bicycles with a well-built carbon frame that aids in the drastic reduction of weight and high tensile strength. Therefore, the growing demand for superior quality and light-weight bicycles is expected to drive the global carbon fiber market in the forthcoming years.
Developed Aerospace Sector in Europe to Aid Growth
Among the regions, the market in Europe is likely to remain at the forefront and hold the highest global carbon fiber market share during the forecast period. This is attributable to developed end-use industries such as aerospace, automotive, and wind energy in countries such as Germany and France. On the other hand, North America is expected to hold the second position in the market during the projected horizon. This is ascribable to increasing adoption of technology and growing awareness for health and fitness amongst the people between 2019 and 2026.
Gain More Insights into the Carbon Fiber Market Research Report:
List of the Companies Operating in the Market:
Hexcel Corporation
Mitsubishi Chemical Carbon Fiber and Composites Inc.
SGL Carbon SE, Teijin Limited
Toray Industries Inc
Jiangsu Hengshen Co. Ltd.
Zhongfu Shenying Carbon Fiber Co. Ltd
Weihai Guangwei Composites Co. Ltd.
Teijin Announces Expansion of Carbon Fiber Production to Strengthen Product Portfolio
In June 2020, Teijin Carbon Europe GmbH, a leading carbon fiber supplier, announced its plan to expand the production capacity by 40% for its German-produced chopped carbon fiber. According to the company, the expansion of its production capacity is aimed at catering to the increasing demand from European electronics manufacturers and medical industries. The global carbon fiber market report mentions that the companies are striving to gain maximum in terms of revenue by adopting strategies such as the expansion of facilities, product expansion offerings, partnership, and collaboration during the forecast period.
Cards you may also be interested in
Therapeutic Drug Monitoring Market - Industry Growth, Dynamics, Segmentation and Forecast
According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the TDM Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025. Growth Driver: Importance of TDM in Organ Transplant Procedures; Conducting TDM for immunosuppressive medications is an essential tool in the management of patients undergoing solid organ transplantation. A person receiving an organ transplant is prescribed immunosuppressants so that the body does not reject the organ. When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy and ensure an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present different pharmacodynamics and pharmacokinetics, so achieving this goal with immunosuppressant therapy monitoring can be challenging. TDM is used before administering immunosuppressants as it minimizes the pharmacokinetic component of variability. Improper drug concentrations in immunosuppressants can lead to adverse effects on transplant patients. Supra-therapeutic drug concentrations can put the patient at risk of over-immunosuppression, which may cause infection. On the other hand, sub-therapeutic drug concentrations can cause the recipient’s body to reject an allograft. This inter-individual variability in drug concentrations creates the need for TDM. Download PDF Brochure: North America commanded the largest share of the therapeutic drug monitoring market in 2019. Geograpgically, Segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America commanded the largest share of the market. Increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region, coupled with initiatives taken by different government associations, are anticipated to boost the market growth in the region. The major players operating in this therapeutic drug monitoring market are Abbott Laboratories (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux (France), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), Randox Laboratories (Ireland), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (United Kingdom), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments & Chemicals GmbH (Germany), Grifols (Spain), Exagen Inc. (U.S.), Theradiag (France), R-Biopharm AG (Germany), apDia Group (Belgium), BioTeZ Berlin-Buch GmbH (Belgium), Eagle Biosciences Inc. (U.S.), JASEM Laboratory Systems and Solutions A.S (Turkey), Aalto Scientific (U.S.), Immundiagnostik AG (Germany), and UTAK (U.S.). Request Sample Pages: Immunoassays is expected to hold the largest share of the TDM Market in 2020 Based on technology, segmented into immunoassays and chromatography-MS. In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation. Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020 On the basis of class of drug, the TDM Market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs. Hospital laboratories segment commanded the largest share of the TDM Market in 2019 By end user, the Therapeutic Drug Monitoring Market is segmented into hospital laboratories, commercial & private laboratories, and other end users. Hospital laboratories accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the availability of advanced healthcare facilities in hospitals and the rising incidences of chronic diseases. Speak to Analyst:
Zeo Taxi Pages List for Taxi Booking #travel #cabs #carrental #taxiservice #cabservice #taxiservices #cabservices #taxibooking #cabbooking #carhire #taxihire #cabhire #carbooking #taxirental #cabrental #zeotaxi #cabonhire #taxionhire #booktaxi